Effects of medicated diet to eradicate Helicobacter spp. on growth, pathology, and infection status in Rag1-/- and nude mice

Journal of the American Association for Laboratory Animal Science

Volumn 53, Issue 3, 2014, Pages 238-245

  Garrett, Caroline M ^a   Muth, Dillon ^a   Watson, Julie ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BODY WEIGHT; CONTROLLED STUDY; DIET; DISEASE SEVERITY; ESOPHAGUS DISEASE; FEMALE; HELICOBACTER; HISTOPATHOLOGY; HYPERKERATOSIS; IMMUNE DEFICIENCY; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WEANING;

ANIMALS; ANTI-BACTERIAL AGENTS; BODY WEIGHT; CECUM; DIET; FECES; HELICOBACTER; HELICOBACTER INFECTIONS; HOMEODOMAIN PROTEINS; IMMUNOCOMPROMISED HOST; MICE; MICE, INBRED C57BL; MICE, NUDE; MICE, SCID; POLYMERASE CHAIN REACTION; RANDOM ALLOCATION; RODENT DISEASES;

EID: 84900543695     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Artwohl JE, Purcell JE, Fortman JD. 2008. The use of cross-foster rederivation to eliminate murine norovirus, Helicobacter spp., and murine hepatitis virus from a mouse colony. J Am Assoc Lab Anim Sci 47:19-24.
2. Beckwith CS, Franklin CL, Hook RR Jr, Besch-Williford CL, Riley LK. 1997. Fecal PCR assay for diagnosis of Helicobacter infection in laboratory rodents. J Clin Microbiol 35:1620-1623.
3. Bohr UR, Selgrad M, Ochmann C, Backert S, Konig W, Fenske A, Wex T, Malfertheiner P. 2006. Prevalence and spread of enterohepatic Helicobacter species in mice reared in a specific-pathogen-free animal facility. J Clin Microbiol 44:738-742.
4. Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G, Viney JL, Maggio-Price L. 2001. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol 281:G764-G778.
5. Butaye P, Devriese LA, Haesebrouck F. 2003. Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria. Clin Microbiol Rev 16:175-188.
6. Chin EY, Dangler CA, Fox JG, Schauer DB. 2000. Helicobacter hepaticus infection triggers inflammatory bowel disease in T cell receptor alphabeta mutant mice. Comp Med 50:586-594.
7. Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, Li H, Alekseyenko AV, Blaser MJ. 2012. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488:621-626.
8. Cresci G, Nagy LE, Ganapathy V. 2013. Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury. JPEN J Parenter Enteral Nutr 37:763-774.
9. Del Carmen Martino-Cardona M, Beck SE, Brayton C, Watson J. 2010. Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D. J Am Assoc Lab Anim Sci 49:294-299.
10. Dianda L, Hanby AM, Wright NA, Sebesteny A, Hayday AC, Owen MJ. 1997. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 150:91-97.
11. Dubos R, Schaedler RW. 1962. Some biological effects of the digestive flora. Am J Med Sci 244:265-271.
12. Dubos R, Schaedler RW, Costello RL. 1963. The effect of antibacterial drugs on the weight of mice. J Exp Med 117:245-257.
13. Dubos R, Schaedler RW, Stephens M. 1963. The effect of antibacterial drugs on the fecal flora of mice. J Exp Med 117:231-243.
14. Dubos RJ, Schaedler RW. 1962. The effect of diet on the fecal bacterial flora of mice and on their resistance to infection. J Exp Med 115:1161-1172.
15. Eaton KA, Opp JS, Gray BM, Bergin IL, Young VB. 2011. Ulcerative typhlocolitis associated with Helicobacter mastomyrinus in telomerase-deficient mice. Vet Pathol 48:713-725.
16. Foltz CJ, Fox JG, Yan L, Shames B. 1995. Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus. Antimicrob Agents Chemother 39:1292-1294.
17. Foltz CJ, Fox JG, Yan L, Shames B. 1996. Evaluation of various oral antimicrobial formulations for eradication of Helicobacter hepaticus. Lab Anim Sci 46:193-197.
18. Fox JG, Gorelick PL, Kullberg MC, Ge Z, Dewhirst FE, Ward JM. 1999. A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice. Infect Immun 67:1757-1762.
19. Fox JG, MacGregor JA, Shen Z, Li X, Lewis R, Dangler CA. 1998. Comparison of methods of identifying Helicobacter hepaticus in B6C3F1 mice used in a carcinogenesis bioassay. J Clin Microbiol 36:1382-1387.
20. Fox JG, Rogers AB, Whary MT, Taylor NS, Xu S, Feng Y, Keys S. 2004. Helicobacter bilis-associated hepatitis in outbred mice. Comp Med 54:571-577.
21. Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X. 1996. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun 64:3673-3681.
22. Franklin CL, Gorelick PL, Riley LK, Dewhirst FE, Livingston RS, Ward JM, Beckwith CS, Fox JG. 2001. Helicobacter typhlonius sp. nov., a novel murine urease-negative Helicobacter species. J Clin Microbiol 39:3920-3926.
23. Franklin CL, Riley LK, Livingston RS, Beckwith CS, Hook RR Jr, Besch-Williford CL, Hunziker R, Gorelick PL. 1999. Enteric lesions in SCID mice infected with "Helicobacter typhlonicus," a novel urease-negative Helicobacter species. Lab Anim Sci 49:496-505.
24. Garrett WS, Lord GM, Punit S, Lugo-Villarino G, Mazmanian SK, Ito S, Glickman JN, Glimcher LH. 2007. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131:33-45.
25. Institute for Laboratory Animal Research. 2011. Guide for the care and use of laboratory animals, 8th ed. Washington (DC): National Academies Press.
26. Jury J, Gee LC, Delaney KH, Perdue MH, Bonner RA. 2005. Eradication of Helicobacter spp. from a rat breeding colony. Contemp Top Lab Anim Sci 44:8-11.
27. Karlsson FH, Ussery DW, Nielsen J, Nookaew I. 2011. A closer look at bacteroides: phylogenetic relationship and genomic implications of a life in the human gut. Microb Ecol 61:473-485.
28. Kostomitsopoulos N, Donnelly H, Kostavasili I, Paronis E, Alexakos P, Karayannacos P. 2007. Eradication of Helicobacter bilis and H. hepaticus from infected mice by using a medicated diet. Lab Anim (NY) 36:37-40.
29. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274.
30. Li X, Fox JG, Whary MT, Yan L, Shames B, Zhao Z. 1998. SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Infect Immun 66:5477-5484.
31. Lofgren JL, Esmail M, Mobley M, McCabe A, Taylor NS, Shen Z, Erdman S, Hewes C, Whary MT, Fox JG. 2012. Prevalence of murine Helicobacter spp. Infection is reduced by restocking research colonies with Helicobacter-free mice. J Am Assoc Lab Anim Sci 51:436-442.
32. Masoro EJ, Shimokawa I, Higami Y, McMahan CA, Yu BP. 1995. Temporal pattern of food intake not a factor in the retardation of aging processes by dietary restriction. J Gerontol A Biol Sci Med Sci 50A:B48-B53.
33. McCracken VJ, Simpson JM, Mackie RI, Gaskins HR. 2001. Molecular ecological analysis of dietary and antibiotic-induced alterations of the mouse intestinal microbiota. J Nutr 131:1862-1870.
34. Murphy EF, Cotter PD, Hogan A, O'Sullivan O, Joyce A, Fouhy F, Clarke SF, Marques TM, O'Toole PW, Stanton C, Quigley EM, Daly C, Ross PR, O'Doherty RM, Shanahan F. 2013. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 62:220-226.
35. Rishniw M, Rodriguez P, Que J, Burke ZD, Tosh D, Chen H, Chen X. 2011. Molecular aspects of esophageal development. Ann N Y Acad Sci 1232:309-315.
36. Russell RJ, Haines DC, Anver MR, Battles JK, Gorelick PL, Blumenauer LL, Gonda MA, Ward JM. 1995. Use of antibiotics to prevent hepatitis and typhlitis in male scid mice spontaneously infected with Helicobacter hepaticus. Lab Anim Sci 45:373-378.
37. Savage DC, Dubos R. 1968. Alterations in the mouse cecum and its flora produced by antibacterial drugs. J Exp Med 128:97-110.
38. Scavizzi F, Raspa M. 2006. Helicobacter typhlonius was detected in the sex organs of three mouse strains but did not transmit vertically. Lab Anim 40:70-79.
39. Schaedler RW, Dubos RJ. 1962. The fecal flora of various strains of mice. Its bearing on their susceptibility to endotoxin. J Exp Med 115:1149-1160.
40. Sharp JM, Vanderford DA, Chichlowski M, Myles MH, Hale LP. 2008. Helicobacter infection decreases reproductive performance of IL10-deficient mice. Comp Med 58:447-453.
41. Shomer NH, Dangler CA, Marini RP, Fox JG. 1998. Helicobacter bilis/Helicobacter rodentium co-infection associated with diarrhea in a colony of scid mice. Lab Anim Sci 48:455-459.
42. Singletary KB, Kloster CA, Baker DG. 2003. Optimal age at fostering for derivation of Helicobacter hepaticus-free mice. Comp Med 53:259-264.
43. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, Glickman JN, Garrett WS. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569-573.
44. Taylor NS, Xu S, Nambiar P, Dewhirst FE, Fox JG. 2007. Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America. J Clin Microbiol 45:2166-2172.
45. Treuting PM, Dintzis S, editors. 2012. Comparative anatomy and histology: a mouse and human atlas. London (UK): Elsevier.
46. Truett GE, Walker JA, Baker DG. 2000. Eradication of infection with Helicobacter spp. by use of neonatal transfer. Comp Med 50:444-451.
47. Van Keuren ML, Saunders TL. 2004. Rederivation of transgenic and gene-targeted mice by embryo transfer. Transgenic Res 13:363-371.
48. Wachtershauser A, Stein J. 2000. Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr 39:164-171.
49. Ward JM, Anver MR, Haines DC, Benveniste RE. 1994. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol 145:959-968.
50. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ Jr, Gorelick PL, Nagashima K, Gonda MA, Gilden RV, Tully JG, Russell RJ, Benvensite RE, Paster BJ, Dewhirst FE, Donovan JC, Anderson LM, Rice JM. 1994. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86:1222-1227.
51. Whary MT, Fox JG. 2004. Natural and experimental Helicobacter infections. Comp Med 54:128-158.
52. Whary MT, Fox JG. 2006. Detection, eradication, and research implications of Helicobacter infections in laboratory rodents. Lab Anim (NY) 35:25-27.
53. Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, Gill N, Russell SL, Vallance BA, Finlay BB. 2011. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun 79:1536-1545.
54. Zhao Y, Wu J, Li JV, Zhou NY, Tang H, Wang Y. 2013. Gut microbiota composition modifies fecal metabolic profiles in mice. J Proteome Res 12:2987-2999.